SUPERNUS PHARMACEUTICALS, INC. (SUPN) › Total AssetsSUPERNUS PHARMACEUTICALS, INC. (SUPN) — Total AssetsAnnual figures by fiscal year, from SEC filings.2011: $53.73M2012: $93.99M2013: $111.00M2014: $136.78M2015: $188.63M2016: $309.57M2017: $424.46M2018: $977.81M2019: $1.16B2020: $1.50B2021: $1.69B2022: $1.70B2023: $1.28B2024: $1.37B2025: $1.45B$1.45B2011Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.45B+6.2%2024$1.37B+7.1%2023$1.28B-25.0%2022$1.70B+0.8%2021$1.69B+12.3%2020$1.50B+29.6%2019$1.16B+18.7%2018$977.81M+130.4%2017$424.46M+37.1%2016$309.57M+64.1%2015$188.63M+37.9%2014$136.78M+23.2%2013$111.00M+18.1%2012$93.99M+74.9%2011$53.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share